Highlights

array(40) {
  [0]=>
  string(4) "1862"
  ["article_id"]=>
  string(4) "1862"
  [1]=>
  string(64) "Fincons Group and the Municipality of Bari deliver Smart Working"
  ["article_title"]=>
  string(64) "Fincons Group and the Municipality of Bari deliver Smart Working"
  [2]=>
  string(150) "Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innovative agile working London, Apr"
  ["short_description"]=>
  string(150) "Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innovative agile working London, Apr"
  [3]=>
  string(570) "Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innovative agile working London, April 2019 – Fincons Group, a leading IT business consulting company with over 35 years’ experience internationally, and the Municipality of Bari have formed a partnership for a pilot Smart Working project as part of H2020 CITADEL (Empowering Citizens to Transform European Public Administrations, funded by the European Commission) ecosystem. The project envisages the development of...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(570) "Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innovative agile working London, April 2019 – Fincons Group, a leading IT business consulting company with over 35 years’ experience internationally, and the Municipality of Bari have formed a partnership for a pilot Smart Working project as part of H2020 CITADEL (Empowering Citizens to Transform European Public Administrations, funded by the European Commission) ecosystem. The project envisages the development of...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "4"
  ["category"]=>
  string(1) "4"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "65"
  ["rss_id"]=>
  string(2) "65"
  [14]=>
  string(97) "http://www.realwire.com/releases/Fincons-Group-and-the-Municipality-of-Bari-deliver-Smart-Working"
  ["blog_url"]=>
  string(97) "http://www.realwire.com/releases/Fincons-Group-and-the-Municipality-of-Bari-deliver-Smart-Working"
  [15]=>
  string(19) "2019-04-18 16:00:00"
  ["add_date"]=>
  string(19) "2019-04-18 16:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-22 17:12:38"
  ["create_at"]=>
  string(19) "2019-04-22 17:12:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Fincons Group and the Municipality of Bari deliver Smart Working

Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innova

array(40) {
  [0]=>
  string(4) "1914"
  ["article_id"]=>
  string(4) "1914"
  [1]=>
  string(167) "Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP"
  ["article_title"]=>
  string(167) "Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tab"
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tab"
  [3]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the..."
  ["description"]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(300) "https://www.drugs.com/fda/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium-usp-14260.html?utm_source=ddc&utm_medium=rss&utm_campaign=Updated%3A+Torrent+Pharmaceuticals+Limited+Expands+Voluntary+Nationwide+Recall+of+Losartan+Potassium+Tablets%2C+USP+and+L"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/fda/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium-usp-14260.html?utm_source=ddc&utm_medium=rss&utm_campaign=Updated%3A+Torrent+Pharmaceuticals+Limited+Expands+Voluntary+Nationwide+Recall+of+Losartan+Potassium+Tablets%2C+USP+and+L"
  [15]=>
  string(19) "2019-04-18 08:00:00"
  ["add_date"]=>
  string(19) "2019-04-18 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan P

Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its rec

array(40) {
  [0]=>
  string(4) "2125"
  ["article_id"]=>
  string(4) "2125"
  [1]=>
  string(68) "MedHealth Summit Brings Together Cross-Border Innovators and Experts"
  ["article_title"]=>
  string(68) "MedHealth Summit Brings Together Cross-Border Innovators and Experts"
  [2]=>
  string(150) "As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devices will gather in Detroit Thu"
  ["short_description"]=>
  string(150) "As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devices will gather in Detroit Thu"
  [3]=>
  string(405) "As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devices will gather in Detroit Thursday for a daylong conference. The MedHealth Summit, held at Ford Field’s Hall of Legends, will bring together experts and entrepreneurs from across Southeast Michigan and Southwest Ontario for a day of panel discussions, “investor […]"
  ["description"]=>
  string(405) "As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devices will gather in Detroit Thursday for a daylong conference. The MedHealth Summit, held at Ford Field’s Hall of Legends, will bring together experts and entrepreneurs from across Southeast Michigan and Southwest Ontario for a day of panel discussions, “investor […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "37"
  ["rss_id"]=>
  string(2) "37"
  [14]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Ui7A9Zbn1-0/"
  ["blog_url"]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Ui7A9Zbn1-0/"
  [15]=>
  string(19) "2019-04-18 02:53:19"
  ["add_date"]=>
  string(19) "2019-04-18 02:53:19"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

MedHealth Summit Brings Together Cross-Border Innovators and Experts

As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devi

array(40) {
  [0]=>
  string(4) "1865"
  ["article_id"]=>
  string(4) "1865"
  [1]=>
  string(27) "The Era of the Robot Nurse"
  ["article_title"]=>
  string(27) "The Era of the Robot Nurse"
  [2]=>
  string(127) "It’s no longer science fiction. &#nlThe post The Era of the Robot Nurse appeared first on MedTech Intelligence.&#nl"
  ["short_description"]=>
  string(127) "It’s no longer science fiction. &#nlThe post The Era of the Robot Nurse appeared first on MedTech Intelligence.&#nl"
  [3]=>
  string(347) "

It’s no longer science fiction.

&#nl

The post The Era of the Robot Nurse appeared first on MedTech Intelligence.

&#nl" ["description"]=> string(347) "

It’s no longer science fiction.

&#nl

The post The Era of the Robot Nurse appeared first on MedTech Intelligence.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "98" ["rss_id"]=> string(2) "98" [14]=> string(79) "https://www.medtechintelligence.com/feature_article/the-era-of-the-robot-nurse/" ["blog_url"]=> string(79) "https://www.medtechintelligence.com/feature_article/the-era-of-the-robot-nurse/" [15]=> string(19) "2019-04-17 04:00:22" ["add_date"]=> string(19) "2019-04-17 04:00:22" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-04-29 16:09:30" ["create_at"]=> string(19) "2019-04-29 16:09:30" [19]=> string(27) "The_Era_of_the_Robot__Nurse" ["slug"]=> string(27) "The_Era_of_the_Robot__Nurse" }

The Era of the Robot Nurse

It’s no longer science fiction.

&#nl

The post

array(40) {
  [0]=>
  string(4) "1859"
  ["article_id"]=>
  string(4) "1859"
  [1]=>
  string(108) "FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products from U.S. Market"
  ["article_title"]=>
  string(108) "FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products from U.S. Market"
  [2]=>
  string(153) "Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, according to the agency.&#nlThe post FDA "
  ["short_description"]=>
  string(153) "Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, according to the agency.&#nlThe post FDA "
  [3]=>
  string(598) "

Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, according to the agency.

&#nl

The post FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products from U.S. Market appeared first on MedTech Intelligence.

&#nl" ["description"]=> string(598) "

Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, according to the agency.

&#nl

The post FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products from U.S. Market appeared first on MedTech Intelligence.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "98" ["rss_id"]=> string(2) "98" [14]=> string(154) "https://www.medtechintelligence.com/news_article/fda-orders-boston-scientific-and-coloplast-to-remove-all-remaining-vaginal-mesh-products-from-u-s-market/" ["blog_url"]=> string(154) "https://www.medtechintelligence.com/news_article/fda-orders-boston-scientific-and-coloplast-to-remove-all-remaining-vaginal-mesh-products-from-u-s-market/" [15]=> string(19) "2019-04-17 02:15:07" ["add_date"]=> string(19) "2019-04-17 02:15:07" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-04-22 13:42:55" ["create_at"]=> string(19) "2019-04-22 13:42:55" [19]=> string(0) "" ["slug"]=> string(0) "" }

FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products f

Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, accor

array(40) {
  [0]=>
  string(4) "1972"
  ["article_id"]=>
  string(4) "1972"
  [1]=>
  string(32) "How do I boost low staff morale?"
  ["article_title"]=>
  string(32) "How do I boost low staff morale?"
  [2]=>
  string(130) "Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and engagement."
  ["short_description"]=>
  string(130) "Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and engagement."
  [3]=>
  string(130) "Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and engagement."
  ["description"]=>
  string(130) "Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and engagement."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(136) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/how-do-i-boost-low-staff-morale/20205723.article"
  ["blog_url"]=>
  string(136) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/how-do-i-boost-low-staff-morale/20205723.article"
  [15]=>
  string(19) "2019-04-16 19:58:00"
  ["add_date"]=>
  string(19) "2019-04-16 19:58:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:55"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

How do I boost low staff morale?

Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and e

array(40) {
  [0]=>
  string(4) "1866"
  ["article_id"]=>
  string(4) "1866"
  [1]=>
  string(57) "Growth in Medical Devices Spurs Recruitment Challenges"
  ["article_title"]=>
  string(57) "Growth in Medical Devices Spurs Recruitment Challenges"
  [2]=>
  string(153) "In addition, in workforce optimization, retention plays an equally important role as recruitment.&#nlThe post Growth in Medical Devices Spurs Recruitment"
  ["short_description"]=>
  string(153) "In addition, in workforce optimization, retention plays an equally important role as recruitment.&#nlThe post Growth in Medical Devices Spurs Recruitment"
  [3]=>
  string(452) "

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post Growth in Medical Devices Spurs Recruitment Challenges appeared first on MedTech Intelligence.

&#nl" ["description"]=> string(452) "

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post Growth in Medical Devices Spurs Recruitment Challenges appeared first on MedTech Intelligence.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "98" ["rss_id"]=> string(2) "98" [14]=> string(98) "https://www.medtechintelligence.com/column/growth-in-medical-devices-spurs-recruitment-challenges/" ["blog_url"]=> string(98) "https://www.medtechintelligence.com/column/growth-in-medical-devices-spurs-recruitment-challenges/" [15]=> string(19) "2019-04-16 19:00:00" ["add_date"]=> string(19) "2019-04-16 19:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-04-29 16:09:31" ["create_at"]=> string(19) "2019-04-29 16:09:31" [19]=> string(0) "" ["slug"]=> string(0) "" }

Growth in Medical Devices Spurs Recruitment Challenges

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post

array(40) {
  [0]=>
  string(4) "1860"
  ["article_id"]=>
  string(4) "1860"
  [1]=>
  string(55) "Growth in Medical Devices Spurs Recruitment Challenges"
  ["article_title"]=>
  string(55) "Growth in Medical Devices Spurs Recruitment Challenges"
  [2]=>
  string(153) "In addition, in workforce optimization, retention plays an equally important role as recruitment.&#nlThe post Growth in Medical Devices Spurs Recruitment"
  ["short_description"]=>
  string(153) "In addition, in workforce optimization, retention plays an equally important role as recruitment.&#nlThe post Growth in Medical Devices Spurs Recruitment"
  [3]=>
  string(452) "

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post Growth in Medical Devices Spurs Recruitment Challenges appeared first on MedTech Intelligence.

&#nl" ["description"]=> string(452) "

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post Growth in Medical Devices Spurs Recruitment Challenges appeared first on MedTech Intelligence.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "98" ["rss_id"]=> string(2) "98" [14]=> string(98) "https://www.medtechintelligence.com/column/growth-in-medical-devices-spurs-recruitment-challenges/" ["blog_url"]=> string(98) "https://www.medtechintelligence.com/column/growth-in-medical-devices-spurs-recruitment-challenges/" [15]=> string(19) "2019-04-16 19:00:00" ["add_date"]=> string(19) "2019-04-16 19:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-04-22 13:42:55" ["create_at"]=> string(19) "2019-04-22 13:42:55" [19]=> string(55) "Growth_in_Medical_Devices_Spurs_Recruitment__Challenges" ["slug"]=> string(55) "Growth_in_Medical_Devices_Spurs_Recruitment__Challenges" }

Growth in Medical Devices Spurs Recruitment Challenges

In addition, in workforce optimization, retention plays an equally important role as recruitment.

&#nl

The post

array(40) {
  [0]=>
  string(4) "1843"
  ["article_id"]=>
  string(4) "1843"
  [1]=>
  string(90) "Worldwide first and only shotgun lipidomics service provider with official GMP certificate"
  ["article_title"]=>
  string(90) "Worldwide first and only shotgun lipidomics service provider with official GMP certificate"
  [2]=>
  string(150) "Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide "
  ["short_description"]=>
  string(150) "Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide "
  [3]=>
  string(579) "Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health – especially in the pharma industry. This is why quality control plays a central role in manufacturing and developing pharmaceutical products. GMP certifications are issued by governmental authorities to ensure product quality...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(579) "Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health – especially in the pharma industry. This is why quality control plays a central role in manufacturing and developing pharmaceutical products. GMP certifications are issued by governmental authorities to ensure product quality...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "64"
  ["rss_id"]=>
  string(2) "64"
  [14]=>
  string(105) "http://www.realwire.com/releases/Worldwide-first-shotgun-lipidomics-service-provider-with-GMP-certificate"
  ["blog_url"]=>
  string(105) "http://www.realwire.com/releases/Worldwide-first-shotgun-lipidomics-service-provider-with-GMP-certificate"
  [15]=>
  string(19) "2019-04-16 17:00:00"
  ["add_date"]=>
  string(19) "2019-04-16 17:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-22 13:42:54"
  ["create_at"]=>
  string(19) "2019-04-22 13:42:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Worldwide first and only shotgun lipidomics service provider with official GMP certificate

Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical produc

array(40) {
  [0]=>
  string(4) "4526"
  ["article_id"]=>
  string(4) "4526"
  [1]=>
  string(47) "17th Annual Pharmaceutical IT and Data Congress"
  ["article_title"]=>
  string(47) "17th Annual Pharmaceutical IT and Data Congress"
  [2]=>
  string(150) "We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic i"
  ["short_description"]=>
  string(150) "We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic i"
  [3]=>
  string(513) "We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions&#nlOver 50 presentations and case studies focusing on the key developments in Big Data, R&D informatics, translational informatics, NGS informatics and Bioinformatics and real-world evidence and real-world data.&#nlIncluding 5 interactive streams:&#nl- Big Data, FAIR data, Translational Informatics, Blockchain- Cloud Computing, Data Analy..."
  ["description"]=>
  string(513) "We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions&#nlOver 50 presentations and case studies focusing on the key developments in Big Data, R&D informatics, translational informatics, NGS informatics and Bioinformatics and real-world evidence and real-world data.&#nlIncluding 5 interactive streams:&#nl- Big Data, FAIR data, Translational Informatics, Blockchain- Cloud Computing, Data Analy..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(79) "https://www.pharmiweb.com/event/17th-annual-pharmaceutical-it-and-data-congress"
  ["blog_url"]=>
  string(79) "https://www.pharmiweb.com/event/17th-annual-pharmaceutical-it-and-data-congress"
  [15]=>
  string(19) "2019-04-16 15:39:30"
  ["add_date"]=>
  string(19) "2019-04-16 15:39:30"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

17th Annual Pharmaceutical IT and Data Congress

We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and inter

array(40) {
  [0]=>
  string(4) "1993"
  ["article_id"]=>
  string(4) "1993"
  [1]=>
  string(112) "Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design"
  ["article_title"]=>
  string(112) "Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design"
  [2]=>
  string(150) "CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to de"
  ["short_description"]=>
  string(150) "CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to de"
  [3]=>
  string(248) "CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the..."
  ["description"]=>
  string(248) "CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/wave-sciences-announces-suvodirsen-phase-1-safety-tolerability-data-phase-2-3-clinical-trial-design-18135.html?utm_source=ddc&utm_medium=rss&utm_campaign=Wave+Life+Sciences+Announces+Suvodirsen+Phase+1+Safety+and+Tolerability+Data+and+Phase+2%2F3+Clinical+Trial+"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/wave-sciences-announces-suvodirsen-phase-1-safety-tolerability-data-phase-2-3-clinical-trial-design-18135.html?utm_source=ddc&utm_medium=rss&utm_campaign=Wave+Life+Sciences+Announces+Suvodirsen+Phase+1+Safety+and+Tolerability+Data+and+Phase+2%2F3+Clinical+Trial+"
  [15]=>
  string(19) "2019-04-16 15:05:50"
  ["add_date"]=>
  string(19) "2019-04-16 15:05:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3

CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic med

array(40) {
  [0]=>
  string(4) "1994"
  ["article_id"]=>
  string(4) "1994"
  [1]=>
  string(97) "AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1"
  ["article_title"]=>
  string(97) "AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1"
  [2]=>
  string(150) "Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Zolgensma® (onasemnogene ab"
  ["short_description"]=>
  string(150) "Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Zolgensma® (onasemnogene ab"
  [3]=>
  string(249) "Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Zolgensma® (onasemnogene abeparvovec-xioi; AVXS-101)[1] in spinal muscular atrophy (SMA) Type 1 showed prolonged event-free..."
  ["description"]=>
  string(249) "Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Zolgensma® (onasemnogene abeparvovec-xioi; AVXS-101)[1] in spinal muscular atrophy (SMA) Type 1 showed prolonged event-free..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(283) "https://www.drugs.com/clinical_trials/avexis-data-reinforce-effectiveness-zolgensma-treating-spinal-muscular-atrophy-sma-type-1-18122.html?utm_source=ddc&utm_medium=rss&utm_campaign=AveXis+Data+Reinforce+Effectiveness+of+Zolgensma+in+Treating+Spinal+Muscular+Atrophy+%28SMA%29+Type+1"
  ["blog_url"]=>
  string(283) "https://www.drugs.com/clinical_trials/avexis-data-reinforce-effectiveness-zolgensma-treating-spinal-muscular-atrophy-sma-type-1-18122.html?utm_source=ddc&utm_medium=rss&utm_campaign=AveXis+Data+Reinforce+Effectiveness+of+Zolgensma+in+Treating+Spinal+Muscular+Atrophy+%28SMA%29+Type+1"
  [15]=>
  string(19) "2019-04-16 13:04:04"
  ["add_date"]=>
  string(19) "2019-04-16 13:04:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA)

Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Z